Breathing After COVID-19

• Sponsor: Trakya University (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT04944342
• Collaborator: (none)
• Enrollment: 20
• Anticipated Duration (Months): 1.1

Study Details

Study Description

Brief Summary

This research; It will be done to perform thoracic movement analysis of young adult individuals who have survived COVID-19 and to compare them with those without a history of COVID-19.

Condition or Disease	Intervention/Treatment	Phase
Gait; Covid19; Thorax Anomalies	Other: No intervention.

Detailed Description

This research; It will be done to perform thoracic movement analysis of young adult individuals who have survived COVID-19 and to compare them with those without a history of COVID-19.

Individuals' sternal movements using motion analysis sensors; will be recorded in sitting position, standing, and walking. Sternal movement of the person; It will be recorded during relaxed breathing and deep breathing. They will also be asked to walk on the treadmill in such a way as to collect at least 500 steps.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 20 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: Thoracal Motion After COVID-19 Disease
• Anticipated Study Start Date: Jun 25, 2021
• Anticipated Primary Completion Date: Jun 30, 2021
• Anticipated Study Completion Date: Jul 30, 2021

Arms and Interventions

Arm	Intervention/Treatment
Individuals who have had COVID-19. Individuals who have had COVID-19 and who treated by a standart medical treatment at home.	Other: No intervention.; No intervention.
Individuals who have not a COVID-19 illness history. Individuals who have not a COVID-19 illness history.	Other: No intervention.; No intervention.

Outcome Measures

Primary Outcome Measures

1. Thoracal motion while normal breathing at sitting. [At first day.]

   Sensor - based thoracal motion assesment while normal breathing at sitting will be utilized.

2. Thoracal motion while normal breathing at standing. [At first day.]

   Sensor - based thoracal motion assesment while normal breathing at standing will be utilized.

3. Thoracal motion while deep breathing at sitting. [At first day.]

   Sensor - based thoracal motion assesment while normal breathing at sitting will be utilized.

4. Thoracal motion while deep breathing at standing. [At first day.]

   Sensor - based thoracal motion assesment while deep breathing at standing will be utilized.

5. Thoracal motion at walk. [At first day.]

   Sensor - based thoracal motion assesment at walk will be utilized.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 30 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• to be voluntary.

• have COVID-19 illness history.

• No COVID-19 illness history.

• treated by a standard medical treatment (vitamins, blood thinners, anti-viral drugs)

Exclusion Criteria:

• have another chronic disease such as systemic, orthopedic or neurologic.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Trakya University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Hilal Hotaman, Assoc Prof, Trakya University
• ClinicalTrials.gov Identifier: NCT04944342
• Other Study ID Numbers: 2021/64
• First Posted: Jun 29, 2021
• Last Update Posted: Jun 29, 2021
• Last Verified: Jun 1, 2021

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of Jun 29, 2021